Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas.

Press Release - Artes Medical, In. (ARTE-Nasdaq)

wpe11.jpg (7184 bytes)

“Our company is in the medical device space marketing an injectable aesthetic product, ArteFill, that is a treatment for facial wrinkles. As we all know, baby boomers are aging and looking for a way to age gracefully. We have developed the first and only injectable wrinkle filler that has a permanent component that provides a long-term effect compared to the existing dermal fillers on the market that are all temporary in nature and required repeated and frequent injections. ..  - Diane S. Goostree (ARTE) (Interview published April 12, 2007)

The Most Powerful Name In Corporate News and Information.

CURRENT ISSUE  |  COVER ARCHIVES  |   INDEX   |  CONTACT  |  FINANCIALS  |  MARKETING SERVICES   |   HOME PAGE


CEOCFO
-Members Login

Become A Member!



 

Artes Medical to Announce 2007 Year End Financial Results

SAN DIEGO--(BUSINESS WIRE)--March 11, 2008--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill(R) is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of "smile line" wrinkles, announced that it will release its financial results for the year ended December 31, 2007 on Thursday, March 13, 2008 at 1:30 p.m. Pacific Time.

Artes Medical will host a webcast and conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on March 13, 2008 to discuss the financial results. The dial in numbers are (866) 713-8563 for domestic callers, and (617) 597-5311 for international callers. The passcode for both domestic and international callers is 25110387. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.artesmedical.com. Participating in the call will be Diane S. Goostree, President and Chief Executive Officer and Peter C. Wulff, Executive Vice President and Chief Financial Officer.

After the live webcast the call will remain available on Artes Medical's website for at least 30 days following the presentation. In addition, a telephonic reply of the call will be available for 7 days. The replay dial-in numbers are (888) 286-8010 for domestic callers, and (617) 801-6888 for international callers. The passcode for both domestic and international callers is 51623100.

About Artes Medical, Inc.

Artes Medical is a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets. The Company's initial product, ArteFill, is being marketed to men and women as a treatment option for the correction of nasolabial folds. Additional information about Artes Medical and ArteFill is available at www.artesmedical.com and www.artefill.com.

Artes Medical(R) and ArteFill(R) are registered trademarks of Artes Medical, Inc.

CONTACT: Artes Medical, Inc.
Cheryl Monblatt Allen, 858-550-9999 (Investors)
callen@artesmedical.com or
Manning Selvage & Lee
Kelley Childrey, 323-866-6003 (Media)
kelley.childrey@mslpr.com

SOURCE: Artes Medical, Inc.


			

		




    

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.